A new year may have dawned, but South Korea remains engulfed in a political crisis stemming from a failed martial law attempt in early December which has led to the opposition-controlled parliament’s impeachment of both President Suk-Yeol Yoon and Acting President Duck-Soo Han in less than a month.
But the country’s health authorities appear intent to focus on business as usual and have vowed to pursue their key policy agendas this year. For its part, the domestic biopharma industry has pledged to overcome the current uncertain and difficult period
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?